Skip to main content
Signal8

Simon Amy

SEC insider (Form 3/4/5 filer). CIK 0001963879. Chief Medical Officer at Beam Therapeutics Inc. (BEAM). 12 reported Form 4/5 transactions since Sep 2024; latest on Jul 27, 2026. Located in CAMBRIDGE, MA.

Companies Simon Amy has filed insider reports for

  • Beam Therapeutics Inc. (BEAM): Officer, Chief Medical Officer
Simon Amy profile photo

Simon Amy

CIK: 0001963879

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)7 (58.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (41.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Beam Therapeutics Inc. logo
BEAM

Beam Therapeutics Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (12 total)

  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jul 27, 2026
    Sale
    Direct
    16.7K shares at avg. $25.74$429K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jun 30, 2026
    Sale
    Direct
    373 shares at avg. $34.73$13K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Apr 1, 2026
    Sale
    Direct
    6.7K shares at avg. $24.58$165K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Mar 31, 2026
    Award
    Direct
    31.8K shares-
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jan 31, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    88.5K shares-
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Dec 31, 2025
    Award
    Direct
    12.5K shares-
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jul 3, 2025
    Sale
    Direct
    876 shares at avg. $20.12$18K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Jul 1, 2025
    Sale
    Direct
    374 shares at avg. $16.94$6K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Apr 2, 2025
    Sale
    Direct
    21K shares at avg. $17.73$372K
  • Beam Therapeutics Inc. logo
    BEAM

    Beam Therapeutics Inc.

    Apr 1, 2025
    Sale
    Direct
    9.6K shares at avg. $18.35$176K

1-10 of 12